Medical Oncology & Blood Disorders Llp is categorized under Oncologists in Hartford, CT and active since 2012.
Medical Oncology & Blood Disorders Llp was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Michael A Reale at the company’s single location by writing to 43 Woodland St, Hartford, Connecticut CT 06105 or by phoning (860) 527-5803. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medical Oncology & Blood Disorders Llp |
| Contact Person: | Michael A Reale |
| Address: | 43 Woodland St, Hartford, Connecticut 06105 |
| Phone Number: | (860) 527-5803 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Medical Oncology & Blood Disorders Llp was started in 2012 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael A Reale for inquiries that concern Medical Oncology & Blood Disorders Llp by calling the company number (860) 527-5803, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Oncology & Blood Disorders Llp can be found at the coordinates 41.770477,-72.701657 as well as the street address 43 Woodland St in Hartford, Connecticut 06105.
For its online presence, you may visit Medical Oncology & Blood Disorders Llp’s website at and engage with its social media outlets through on Twitter and on Facebook.